Discover
CRBU
Caribou Biosciences, Inc.
1.61
1 x 1.50
22 x 1.60
bid
ask
-
0.09
5.29%
700 @ 04:00 PM
1.60 -0.01 (0.62%)
| Ytd | 1.26% | |
| 1y | -17.44% |
1.60
day range
1.72
1.38
52 week range
3.54
| Open | 1.72 | Prev Close | 1.70 | Low | 1.60 | High | 1.72 | Mkt Cap | 159.68M |
| Vol | 1.09M | Avg Vol | 1.95M | EPS | -1.19 | P/E | -1.35 | Forward P/E | -0.90 |
| Beta | 2.26 | Short Ratio | 4.55 | Inst. Own | 62.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.72 | 200-d Avg | 1.84 | 1yr Est | 12.50 |
| Income Statement | |||
| Operating Expenses | 28.68M | ||
| Research and Development Expense | 20.61M | ||
| Selling, General and Administrative Expense | 8.07M | ||
| Operating Income | -28.68M | ||
| Net Income | -25.08M | ||
| Net Income Common Stock | -25.08M | ||
| Net Income Common Stock (USD) | -25.08M | ||
| Consolidated Income | -25.08M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -25.08M | ||
| Earning Before Interest & Taxes (USD) | -25.08M | ||
| Weighted Average Shares | 95.86M | ||
| Weighted Average Shares Diluted | 95.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.06M | ||
| Cash and Equivalents (USD) | 12.06M | ||
| Investments | 106.57M | ||
| Investments Current | 105.57M | ||
| Investments Non-Current | 1.00M | ||
| Trade and Non-Trade Receivables | 1.67M | ||
| Current Assets | 122.38M | ||
| Property, Plant & Equipment Net | 23.48M | ||
| Total Assets | 149.00M | ||
| Debt Current | 1.29M | ||
| Total Debt | 26.95M | ||
| Current Liabilities | 19.67M | ||
| Debt Non-Current | 25.66M | ||
| Total Liabilities | 46.98M | ||
| Accumulated Retained Earnings (Deficit) | -621.60M | ||
| Accumulated Other Comprehensive Income | -23.00K | ||
| Shareholders Equity | 102.02M | ||
| Shareholders Equity (USD) | 102.02M | ||
| Assets Non-Current | 26.62M | ||
| Total Debt (USD) | 26.95M | ||
| Deferred Revenue | 2.64M | ||
| Liabilities Non-Current | 27.31M | ||
| Trade and Non-Trade Payables | 3.50M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 964.00K | ||
| Net Cash Flow from Financing | 2.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -303.00K | ||
| Capital Expenditure | -72.00K | ||
| Issuance (Purchase) of Equity Shares | 2.70M | ||
| Net Cash Flow from Investing | 23.99M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 24.06M | ||
| Net Cash Flow from Operations | -26.98M | ||
| Share Based Compensation | 2.36M | ||